Acknowledgements
SAKK, Cancer
CANCER
We thank the patients and investigators at all study sites for participation in the study. This work was supported by the Swiss Group for Clinical Cancer Research (SAKK), the LOAIV funds, managed by curafutura, santésuisse, and pharmaSuisse, and a grant from Krebsliga Schweiz. Julia Balfour, of NorthStar Medical Writing Services, Dundee, Scotland, provided English-language editing support for the manuscript, with funding from SAKK.